{
    "title": "Nektar withdraws application for opioid painkiller after FDA panel's vote",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7887891/U-S-FDA-panel-votes-against-approval-Nektars-opioid-painkiller.html",
    "date": "2020-01-14",
    "keywords": [
        "pain",
        "company",
        "drug",
        "fda",
        "panel",
        "abuse",
        "joseph",
        "chander",
        "approval",
        "nktr181",
        "rate",
        "brain",
        "member",
        "vishwadha",
        "jan",
        "tuesday",
        "application",
        "painkiller",
        "food",
        "administration",
        "pill",
        "misuse",
        "lack",
        "potential",
        "toxicity",
        "trading",
        "investing",
        "program",
        "nektar",
        "effect",
        "entry",
        "lee",
        "hoffer",
        "case",
        "reserve",
        "university",
        "cleveland",
        "ohio",
        "problem",
        "addiction",
        "onset",
        "acetaminophen",
        "severity",
        "idea",
        "data",
        "dont",
        "end",
        "day",
        "standpoint",
        "efficacy",
        "safety",
        "dr",
        "sherif",
        "zaafran",
        "vice",
        "chairman",
        "governance",
        "board",
        "saumya",
        "sibi",
        "shubham",
        "bengaluru",
        "editing",
        "daniel",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}